"Atogepant Cuts Rebound Headaches by 50% in Migraine Patients"
A new study shows that the migraine-preventive drug atogepant significantly reduces the occurrence of rebound headaches in people with chronic migraines. By taking atogepant daily, patients experienced fewer migraine days and reduced their need for additional pain medications, which are often the cause of rebound headaches. The study, led by Dr. Peter J. Goadsby, involved 755 participants and demonstrated that atogepant effectively alleviates migraine-related pain by relaxing blood vessels, preventing them from becoming too large and irritating the meninges.
